- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05313373
The Effect of Virtual Reality on Women Undergoing Hysterosalpingography
The Effect of Virtual Reality On Women's Perceptıons of Fear, Pain, Anxiety and Satisfaction Undergoing Hysterosalpingography; A Randomized Controlled Research
The aim of this study is to determine the effect of virtual reality on perceived pain, anxiety, fear, physiological reactions and satisfaction in women during the HSG procedure.
Hypotheses H01; In the HSG procedure, there was no difference between the pain score of the virtual reality group and the pain score of the control group.
H02; In the HSG procedure, there was no difference between the anxiety score of the virtual reality group and the anxiety score of the control group.
H03; In the HSG procedure, there was no difference between the satisfaction score of the virtual reality group and the satisfaction score of the control group.
H04; In the HSG procedure, there was no difference between the vital signs of the virtual reality group and the control group.
H05; In the HSG procedure, there was no difference between the fear score of the virtual reality group and the fear score of the control group.
The study will be carried out in two different groups. The practice will start with meeting the women who apply to the Radiology clinic for an HSG. After the women are evaluated in terms of eligibility criteria for the research, the women who are eligible will be informed about the research and written informed consent will be obtained from the women who accept. The random distribution of women to the study groups will be carried out using the Block Randomization method. The following applications will be made to the groups.
Virtual Reality Group In addition to the routine procedure, virtual reality glasses will be applied to the women in the virtual reality group of the research. Virtual reality glasses is a device that works on compatible smart mobile phones. After being taken to the gynecological table for the HSG procedure, the women included in the experimental group will be made to watch a video lasting an average of 10 minutes with virtual reality glasses until the procedure is completed. While watching the video, the relaxing music of the video will be played in the practice room with a bluetooth speaker.
Control Group Patients in the control group of the study will not be subjected to any treatment other than the routine procedure.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06100
- Ankara University Fertility Diagnosis, Treatment, Research and Application Center
-
-
Mamak
-
Ankara, Mamak, Turkey, 06100
- Ankara University Fertility Diagnosis, Treatment, Research and Application Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- primary infertility
- Agreeing to participate in the research and obtaining written permission,
- No hearing or vision problems
- The first time HSG procedure will be applied
Exclusion Criteria:
- Didn't watch the whole video
- Those with motion-sensitive diseases such as vertigo, meniere
- Using any pharmacological pain-reducing method within 30 minutes
- Difficulty in the HSG process or completing the process with more than one attempt
- Use of antidepressants or sedatives
- Any history of allergy to radio-opaque dye
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control Group
|
|
Experimental: Virtual Reality Group
|
In addition to the routine procedure, virtual reality glasses will be applied to the women in the virtual reality group of the research.
Virtual reality glasses is a device that works on compatible smart mobile phones.
After being taken to the gynecological table for the HSG procedure, the women included in the experimental group will be made to watch a video lasting an average of 10 minutes with virtual reality glasses until the procedure is completed.
While watching the video, the relaxing music of the video will be played.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in anxiety
Time Frame: immediately before the HSG procedure and immediately after the HSG procedure
|
STAI-S consist of 20 items with four points Likert scales, each (not at all, somewhat, moderately so, very much so).
Scores thus range between 20, indicating a low level of anxiety and 80, indicating a high level.
|
immediately before the HSG procedure and immediately after the HSG procedure
|
Change in the degree of pain experienced during the procedure
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
The pain was assessed using 0-100 mm VAS for determining perceptions of pain during the procedure.
This scale is widely used and has demonstrated reliability and validity in the measurement of acute pain.
A high score on the scale indicated a high level of pain and a score of 0 pointed to no pain at all (Bijur, Silver, & Gallagher, 2001).
Each participant was asked to mark her current level of perceived pain along the scale, with the number corresponding to the marked point recorded as the pain score
|
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
Change in fear
Time Frame: immediately before the HSG procedure, immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
VAS is a 10-cm-long measurement tool.
The left end of the scale reads "no fear at all" and the right end reads "the most intense fear possible".
A high score on the scale indicated a high level of fear and a score of 0 pointed to no fear.
|
immediately before the HSG procedure, immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the degree of satisfaction
Time Frame: 15 minutes after the HSG procedure
|
VAS is a 10-cm-long measurement tool.
The left end of the scale reads "I am not satisfied at all" and the right end reads "very satisfied".
A high score on the scale indicated a high level of satisfied and a score of 0 pointed to no satisfied.
|
15 minutes after the HSG procedure
|
Change in blood pressure
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
mmHg
|
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
Change in heart rate
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
beats per minute (bpm)
|
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
Change in body temperature
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
degrees Celsius
|
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
Change in the saturation of peripheral oxygen SpO2
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
|
|
HSG result
Time Frame: 15 minutes after the HSG procedure
|
both tubes patent, one fallopian tubes occluded, both fallopian tubes occluded
|
15 minutes after the HSG procedure
|
contrast medium volume
Time Frame: during HSG prosedure
|
milliliter (ml)
|
during HSG prosedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 04/49
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterosalpingography
-
Sadiman Kiykac AltinbasCompletedPain During HysterosalpingographyTurkey
-
Ataturk UniversityCompleted
-
ŞERİVAN KARAKUTRecruitingPain | Anxiety | HysterosalpingographyTurkey
-
Cairo UniversityHospital El GezeeraNot yet recruiting
Clinical Trials on Virtual Reality
-
Institut National de la Santé Et de la Recherche...Not yet recruitingSchizophrenia | Bipolar Disorder
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
University of PennsylvaniaNot yet recruitingEnd Stage Kidney Disease
-
The University of Hong KongCompleted
-
Universidad Rey Juan CarlosCompleted
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire; Gustave Roussy, Cancer Campus, Grand... and other collaboratorsTerminated
-
Hacettepe UniversityRecruitingGonarthrosis; PrimaryTurkey
-
Istituto Auxologico ItalianoCompletedGeneralized Anxiety DisorderItaly
-
IRCCS San RaffaeleRecruiting
-
National University of MalaysiaRecruitingPleural EffusionMalaysia